Skip to content
★ Sign in to follow
MG
Total declarations
21
Company
1
▲ Purchases (1 ops.)
€1.2M
▼ Sales (15 ops.)
€102.6M

Latest filing published 27 Jun 2023 for Royalty Pharma plc.

Filing timeline

BuySale
Mario Germano Giuliani

Insider track record

Disclosed buys
1
Disclosed sells
15
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 22 Jun 2020 · 2330 days ago · €1.2M
    -17.2%
    Entry US$50.95 · Close at T+365 US$42.19

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Mario Germano Giuliani: trading record in brief

Mario Germano Giuliani is Director of Royalty Pharma plc, the only company in the record, in 21 filings whose trades run from June 18, 2020 to June 23, 2023. The 15 open-market sales weigh EUR 102,631,603, with a median of EUR 6,980,410, and cluster in September 2022: EUR 11,176,542 on September 7, EUR 10,143,411 on September 8 and EUR 11,017,852 on September 20. The single purchase, EUR 1,248,773, is dated June 18, 2020, and makes up 6% of market trades.

The rest of the record is limited to 1 share grant and 4 other lines. The year 2022 has 15 filings, against 5 in 2020 and 1 in 2023. No filing falls in the last twelve months. Filings are published a median of 3 days after the trade.

At Royalty Pharma plc, 16 of Giuliani's market trades fall within 30 days of a trade by Rory B. Riggs and 11 of a trade by James F. Reddoch, always in the same direction.

Companies and markets linked to Mario Germano Giuliani

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations